Ignite Creation Date:
2025-12-24 @ 4:09 PM
Ignite Modification Date:
2025-12-27 @ 5:45 PM
Study NCT ID:
NCT01931566
Status:
TERMINATED
Last Update Posted:
2019-09-16
First Post:
2013-08-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09-06
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-26
First Submit QC Date:
None
Study First Post Date:
2013-08-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-22
Results First Submit QC Date:
None
Results First Post Date:
2019-08-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-29
Last Update Post Date:
2019-09-16
Last Update Post Date Type:
ACTUAL